CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Nexstim NBS guided active rTMS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03010462
NCT03010462N/ACompleted
CompareCT.gov

A Prospective, Multi-center, Randomized, Sham-controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 hz Rtms Administered to the Contralesional Hemisphere as Adjuvant to Task-oriented Rehabilitation in Patients With Ischemic Stroke

Nexstim Ltd·interventional·Posted Jan 5, 2017·Updated Apr 26, 2021

In Brief

A clinical study evaluating Nexstim NBS guided active rTMS and Nexstim NBS guided sham rTMS for Ischemic Stroke. Completed, enrolled 60 participants across 5 sites.

Detailed Summary

A prospective, multi-center, randomized, sham-controlled, blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment of the upper limb. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 5, 2017
Enrollment StartMar 1, 2017
Primary CompletionAug 15, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.5 years ago

Interventions

Nexstim NBS guided active rTMSdevice

Nexstim NBS guided active rTMS + standardized task-oriented therapy

Nexstim NBS guided sham rTMSdevice

Nexstim NBS guided sham rTMS + standardized task-oriented therapy